Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 570.47% | -99.75% | -96.68% | 32.23% | -84.01% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 99.47% | 48.21% | 149.86% | 877.97% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 393.23% | -74.45% | -85.98% | 50.98% | -- |
|
|
|||||
| Total Current Assets | 393.23% | -74.45% | -85.98% | 50.98% | -- |
| Net Property, Plant & Equipment | 186.93% | 156.40% | 136.23% | 120.68% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -14.71% | -- |
| Total Assets | 355.11% | -54.10% | -77.27% | 65.72% | -- |
|
|
|||||
| Total Accounts Payable | -62.64% | 74.44% | 15.38% | -52.25% | -- |
| Total Accrued Expenses | -3.58% | -13.48% | -39.52% | -15.14% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.90% | -56.47% | -56.76% | -99.82% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -45.85% | 8.43% | -24.34% | -88.19% | -- |
|
|
|||||
| Total Current Liabilities | -45.85% | 8.43% | -24.34% | -88.19% | -- |
| Long-Term Debt | 161.84% | -- | -- | -78.19% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 2,215.38% | 870.77% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.85% | -96.78% | -93.18% | -- | -- |
| Total Liabilities | -87.53% | -80.17% | -75.28% | -77.46% | -- |
|
|
|||||
| Common Stock & APIC | 4.56% | 5.71% | 5.77% | 95.48% | -- |
| Retained Earnings | 28.59% | 8.87% | 3.06% | 15.82% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 94.29% | 81.33% | 75.01% | 90.79% | 31.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 94.29% | 81.33% | 75.01% | 90.79% | 31.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 94.29% | 81.33% | 75.01% | 80.85% | -49.76% |
|
|
|||||